Your browser doesn't support javascript.
loading
A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study.
Rader, Janet S; Sill, Michael W; Beumer, Jan H; Lankes, Heather A; Benbrook, Doris Mangiaracina; Garcia, Francisco; Trimble, Connie; Tate Thigpen, J; Lieberman, Richard; Zuna, Rosemary E; Leath, Charles A; Spirtos, Nick M; Byron, John; Thaker, Premal H; Lele, Shashikant; Alberts, David.
Affiliation
  • Rader JS; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI 53226, United States. Electronic address: jrader@mcw.edu.
  • Sill MW; NRG Oncology/Gynecologic Oncology Group Statistics & Data Center, Roswell Park Cancer Institute, Buffalo, NY 14263, United States. Electronic address: msill@gogstats.org.
  • Beumer JH; Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Department of Pharmaceutical Sciences, School of Pharmacy, Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, United States; Department of Obstetrics and G
  • Lankes HA; NRG Oncology/Gynecologic Oncology Group Statistics & Data Center, Roswell Park Cancer Institute, Buffalo, NY 14263, United States. Electronic address: hlankes@gogstats.org.
  • Benbrook DM; Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73165. Electronic address: Doris-Benbrook@ouhsc.edu.
  • Garcia F; Department of Obstetrics & Gynecology, University of Arizona, Mel & Enid Zuckerman College of Public Health, Tucson, AZ 85724, United States. Electronic address: Francisco.Garcia@pima.gov.
  • Trimble C; Division of Gynecologic Specialties, Johns Hopkins Medical Institutions, Baltimore, MD 21287, United States. Electronic address: ctrimbl@jhmi.edu.
  • Tate Thigpen J; Department of Gynecologic Oncology, University of Mississippi Medical Center, Jackson, MS 39216, United States.
  • Lieberman R; Division of OB/GYN and Pathology, University of Michigan Health System, Ann Arbor, MI 48109, United States. Electronic address: jakrwl@med.umich.edu.
  • Zuna RE; Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, United States. Electronic address: Rosemary-Zuna@ouhsc.edu.
  • Leath CA; Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL 35233, United States. Electronic address: cleath@uabmc.edu.
  • Spirtos NM; Division of Gynecologic Oncology, Women's Cancer Center of Nevada, Las Vegas, NV 89169, United States. Electronic address: nspirtos@wccenter.com.
  • Byron J; Department of OB/GYN, First Health of the Carolinas - Moore Regional Hospital, Southern Pines, NC 28388, United States. Electronic address: JByron@spwhc.com.
  • Thaker PH; Division of Gynecologic Oncology, Washington University School of Medicine, Saint Louis, MO 63110, United States. Electronic address: thakerp@wudosis.wustl.edu.
  • Lele S; Department of Gynecologic Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263, United States. Electronic address: shashi.lele@roswellpark.org.
  • Alberts D; Department of Medical Oncology, The University of Arizona Cancer Center-North Campus, Tucson, AZ 85724, United States. Electronic address: DAlberts@uacc.arizona.edu.
Gynecol Oncol ; 145(2): 291-297, 2017 05.
Article in En | MEDLINE | ID: mdl-28285845
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Dysplasia / Uterine Cervical Neoplasms / Vascular Endothelial Growth Factor A / Celecoxib Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Middle aged Language: En Journal: Gynecol Oncol Year: 2017 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Uterine Cervical Dysplasia / Uterine Cervical Neoplasms / Vascular Endothelial Growth Factor A / Celecoxib Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Middle aged Language: En Journal: Gynecol Oncol Year: 2017 Type: Article